🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 17 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/05/2011 8,58 8,76 8,22 8,34 -2,80% 6,29% 62.250
03/05/2011 8,70 8,88 8,52 8,58 -1,38% 4,14% 45.050
02/05/2011 9,06 9,06 8,64 8,70 -2,68% 4,64% 48.000
29/04/2011 9,06 9,06 8,82 8,94 -0,67% 2,65% 38.167
28/04/2011 9,12 9,12 8,82 9,00 +1,35% 3,29% 44.850
27/04/2011 9,00 9,06 8,70 8,88 +0,00% 4,00% 49.083
26/04/2011 9,18 9,18 8,70 8,88 -2,63% 5,23% 66.050
25/04/2011 9,24 9,24 9,00 9,12 -1,30% 2,60% 27.783
21/04/2011 9,18 9,30 8,82 9,24 +1,32% 5,23% 23.850
20/04/2011 8,76 9,12 8,58 9,12 +5,56% 6,16% 113.250
19/04/2011 8,52 8,82 8,28 8,64 +2,86% 6,34% 81.000
18/04/2011 8,64 9,00 8,16 8,40 -6,67% 9,72% 125.367
15/04/2011 8,94 9,12 8,64 9,00 +0,00% 5,37% 83.450
14/04/2011 9,30 9,30 8,94 9,00 -1,32% 3,87% 77.317
13/04/2011 9,30 9,30 8,88 9,12 -0,65% 4,52% 115.300
12/04/2011 9,18 10,14 9,06 9,18 -1,29% 11,76% 262.600
11/04/2011 8,94 9,54 8,88 9,30 +7,64% 7,38% 199.183
08/04/2011 8,82 8,88 8,64 8,64 -1,37% 2,72% 26.717
07/04/2011 8,82 9,06 8,76 8,76 -0,68% 3,40% 24.483
06/04/2011 8,94 8,94 8,82 8,82 +0,00% 1,34% 20.900
05/04/2011 8,88 9,00 8,76 8,82 -1,34% 2,70% 57.150
04/04/2011 9,00 9,30 8,70 8,94 -1,32% 6,67% 58.317
01/04/2011 9,06 9,12 8,88 9,06 +1,34% 2,65% 49.600
31/03/2011 8,94 9,24 8,70 8,94 -0,67% 6,04% 52.583
30/03/2011 8,88 9,06 8,70 9,00 +1,35% 4,05% 37.000
29/03/2011 8,64 9,00 8,52 8,88 +2,78% 5,56% 57.917
28/03/2011 8,88 9,54 8,58 8,64 +2,86% 10,81% 246.700
25/03/2011 8,40 8,52 8,28 8,40 +1,45% 2,86% 36.817
24/03/2011 8,04 8,52 7,86 8,28 +2,99% 8,21% 104.667
23/03/2011 7,92 8,34 7,68 8,04 +6,35% 8,33% 211.283